Evidence map›Paper›PMID 40524993›Full record

ArticleCureus2025

Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis.

Mackenzie Caruthers, Shaili Kothari, Conor Kelly, Kim M Jordan, Branden Luna

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mackenzie CaruthersInternal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.
Shaili KothariInternal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.
Conor KellyInternal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.
Kim M JordanInternal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.
Branden LunaCritical Care Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory condition resulting in erroneous activation of the immune system. Treatment is directed at the underlying pathology that prompts activation of the immune system and usually includes immunosuppressant therapy, including steroids, etoposide, or rituximab. However, the best treatment for patients with significant infection remains unclear. Few cases of HLH are associated with disseminated histoplasmosis, and there are no clear treatment guidelines in these cases. Due to the significant morbidity and mortality associated with HLH, further investigation is needed to identify the best treatment regimens.

Indexed as

dexamethasoneetoposidehistoplasmosishyperinflammatorylymphohistiocytosis

Identifiers

PMID40524993
PMCPMC12168652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.